222 related articles for article (PubMed ID: 33025472)
1.
Papathanasiou M; Kessler L; Carpinteiro A; Hagenacker T; Nensa F; Umutlu L; Forsting M; Brainman A; Kleinschnitz C; Antoch G; Dührsen U; Schlosser TW; Herrmann K; Rassaf T; Luedike P; Rischpler C
J Nucl Cardiol; 2022 Apr; 29(2):779-789. PubMed ID: 33025472
[TBL] [Abstract][Full Text] [Related]
2. Amyloid PET imaging in cardiac amyloidosis: a pilot study using
Dietemann S; Nkoulou R
Ann Nucl Med; 2019 Aug; 33(8):624-628. PubMed ID: 31140154
[TBL] [Abstract][Full Text] [Related]
3. [18F]-Florbetaben PET/CT for Differential Diagnosis Among Cardiac Immunoglobulin Light Chain, Transthyretin Amyloidosis, and Mimicking Conditions.
Genovesi D; Vergaro G; Giorgetti A; Marzullo P; Scipioni M; Santarelli MF; Pucci A; Buda G; Volpi E; Emdin M
JACC Cardiovasc Imaging; 2021 Jan; 14(1):246-255. PubMed ID: 32771577
[TBL] [Abstract][Full Text] [Related]
4. Improved Quantification of Cardiac Amyloid Burden in Systemic Light Chain Amyloidosis: Redefining Early Disease?
Cuddy SAM; Bravo PE; Falk RH; El-Sady S; Kijewski MF; Park MA; Ruberg FL; Sanchorawala V; Landau H; Yee AJ; Bianchi G; Di Carli MF; Cheng SC; Jerosch-Herold M; Kwong RY; Liao R; Dorbala S
JACC Cardiovasc Imaging; 2020 Jun; 13(6):1325-1336. PubMed ID: 32417333
[TBL] [Abstract][Full Text] [Related]
5. Positron emission tomography (PET) utilizing Pittsburgh compound B (PIB) for detection of amyloid heart deposits in hereditary transthyretin amyloidosis (ATTR).
Pilebro B; Arvidsson S; Lindqvist P; Sundström T; Westermark P; Antoni G; Suhr O; Sörensen J
J Nucl Cardiol; 2018 Feb; 25(1):240-248. PubMed ID: 27645889
[TBL] [Abstract][Full Text] [Related]
6. 18 F-Flutemetamol PET/CT for Transthyretin Amyloid Cardiomyopathy : Timing Matters.
Han EJ; Sung YE; Jung MH; O JH; Youn JC
Clin Nucl Med; 2022 Dec; 47(12):1074-1076. PubMed ID: 36240762
[TBL] [Abstract][Full Text] [Related]
7. Quantification of cardiac amyloid with [
Möckelind S; Axelsson J; Pilebro B; Lindqvist P; Suhr OB; Sundström T
Amyloid; 2020 Sep; 27(3):191-199. PubMed ID: 32400202
[No Abstract] [Full Text] [Related]
8.
Morgenstern R; Yeh R; Castano A; Maurer MS; Bokhari S
J Nucl Cardiol; 2018 Oct; 25(5):1559-1567. PubMed ID: 28176254
[TBL] [Abstract][Full Text] [Related]
9.
Abulizi M; Sifaoui I; Wuliya-Gariepy M; Kharoubi M; Israël JM; Emsen B; Bodez D; Monnet A; Didierlaurent D; Tacher V; Luciani A; Damy T; Deux JF; Itti E
J Nucl Cardiol; 2021 Aug; 28(4):1586-1595. PubMed ID: 31512197
[TBL] [Abstract][Full Text] [Related]
10. Native T1 Mapping, Extracellular Volume Mapping, and Late Gadolinium Enhancement in Cardiac Amyloidosis: A Meta-Analysis.
Pan JA; Kerwin MJ; Salerno M
JACC Cardiovasc Imaging; 2020 Jun; 13(6):1299-1310. PubMed ID: 32498919
[TBL] [Abstract][Full Text] [Related]
11. Detection of cardiac amyloidosis with
Kircher M; Ihne S; Brumberg J; Morbach C; Knop S; Kortüm KM; Störk S; Buck AK; Reiter T; Bauer WR; Lapa C
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1407-1416. PubMed ID: 30798427
[TBL] [Abstract][Full Text] [Related]
12. Myocardial native T2 measurement to differentiate light-chain and transthyretin cardiac amyloidosis and assess prognosis.
Ridouani F; Damy T; Tacher V; Derbel H; Legou F; Sifaoui I; Audureau E; Bodez D; Rahmouni A; Deux JF
J Cardiovasc Magn Reson; 2018 Aug; 20(1):58. PubMed ID: 30115079
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic Accuracy of [
Rosengren S; Skibsted Clemmensen T; Tolbod L; Granstam SO; Eiskjær H; Wikström G; Vedin O; Kero T; Lubberink M; Harms HJ; Flachskampf FA; Baron T; Carlson K; Mikkelsen F; Antoni G; Frost Andersen N; Hvitfeldt Poulsen S; Sörensen J
JACC Cardiovasc Imaging; 2020 Jun; 13(6):1337-1347. PubMed ID: 32417330
[TBL] [Abstract][Full Text] [Related]
14. PET-CT evaluation of amyloid systemic involvement with [
Genovesi D; Vergaro G; Emdin M; Giorgetti A; Marzullo P
J Nucl Cardiol; 2017 Dec; 24(6):2025-2029. PubMed ID: 28326465
[TBL] [Abstract][Full Text] [Related]
15. Cardiac amyloidosis imaging with amyloid positron emission tomography: A systematic review and meta-analysis.
Kim YJ; Ha S; Kim YI
J Nucl Cardiol; 2020 Feb; 27(1):123-132. PubMed ID: 30022405
[TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography in the diagnosis and follow-up of transthyretin amyloid cardiomyopathy patients: A systematic review.
Tingen HSA; Tubben A; van 't Oever JH; Pastoor EM; van Zon PPA; Nienhuis HLA; van der Meer P; Slart RHJA
Eur J Nucl Med Mol Imaging; 2023 Dec; 51(1):93-109. PubMed ID: 37561144
[TBL] [Abstract][Full Text] [Related]
17. Cardiac amyloidosis characterization by kinetic model fitting on [18F]florbetaben PET images.
Santarelli MF; Genovesi D; Scipioni M; Positano V; Favilli B; Giorgetti A; Vergaro G; Landini L; Emdin M; Marzullo P
J Nucl Cardiol; 2022 Aug; 29(4):1919-1932. PubMed ID: 33864226
[TBL] [Abstract][Full Text] [Related]
18. Radionuclide Imaging of Cardiac Amyloidosis.
Joseph V; Julien HM; Bravo PE
PET Clin; 2021 Apr; 16(2):285-293. PubMed ID: 33589384
[TBL] [Abstract][Full Text] [Related]
19. Examining the sensitivity of 18F-NaF PET for the imaging of cardiac amyloidosis.
Martineau P; Finnerty V; Giraldeau G; Authier S; Harel F; Pelletier-Galarneau M
J Nucl Cardiol; 2021 Feb; 28(1):209-218. PubMed ID: 30834499
[TBL] [Abstract][Full Text] [Related]
20. The flutemetamol analogue cyano-flutemetamol detects myocardial AL and ATTR amyloid deposits: a post-mortem histofluorescence analysis.
Abrahamson EE; Padera RF; Davies J; Farrar G; Villemagne VL; Dorbala S; Ikonomovic MD
Amyloid; 2023 Jun; 30(2):169-187. PubMed ID: 36411500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
